This study evaluated long-term outcomes of bioprosthetic and mechanical aortic valve replacement (AVR) using data from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (STS-ACSD).
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Aortic Valve
January 23, 2025
The authors evaluated the five-year outcomes in low-risk patients undergoing isolated surgical aortic valve replacement (SAVR) or SAVR with concomitant procedures within the randomized PARTNER 3 trial. In the PARTNER 3 trial, 454 patients with severe, symptomatic, tricuspid aortic stenosis (AS) underwent surgery and were followed for five years.
January 23, 2025
This study compared isolated primary bioprosthetic surgical aortic valve replacement (SAVR) with isolated redo surgical aortic valve replacement (rSAVR) due to structural valve deterioration (SVD).
January 23, 2025
In this article, the authors aimed to assess whether post-implant transcatheter aortic valve prosthesis multi-detector computed characteristics differ between patients with native tricuspid and bicuspid aortic valve stenosis, as well as the effect on valve performance and clinical outcomes.
January 23, 2025
This retrospective analysis examined trends and outcomes of aortic valve replacement in patients under the age of 65 with aortic stenosis from 2013 to 2021, focusing on transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR).
January 16, 2025
In this study-level meta-analysis of randomized controlled trials (RCTs) evaluating the effect of early aortic valve replacement (AVR) versus clinical surveillance (CS) in patients with asymptomatic severe aortic stenosis (AS), four RCTs were identified and included for analysis: AVATAR, RECOVERY, EARLY TAVR, EVOLVED.
January 9, 2025
The treatment of aortic valve disease has evolved, and it is expected that TAVR will be available to most patients in the next few years. However, TAVR with a bioprosthesis will continue to be indicated and used. It is well documented that the use of a small valve, particularly in young patients, presents clinical challenges.
December 27, 2024
This study investigated the impact of patient-prosthesis mismatch (PPM) on long-term mortality and reoperation rates over a 15-year follow-up in patients who underwent biologic aortic valve replacement.
December 19, 2024
Surgeons at the West Virginia University Heart and Vascular Institute performed the world’s first combined robotic aortic valve replacement (AVR) and coronary artery bypass grafting (CABG) through a single small incision. The groundbreaking procedure, led by Dr.
December 12, 2024
This article examines the results of the COMMENCE trial, which evaluated the safety and effectiveness of surgical aortic valve replacement using RESILIA tissue valves during a five-year period in patients with native bicuspid aortic valves, comparing outcomes with those of patients with tricuspid aortic valves.